(RVNC) Revance Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Revance Therapeutics | (RVNC) share price targets
Complete technical analysis of Revance Therapeutics (RVNC) by charts plus indicators, forecast predictions and share price targets for Revance Therapeutics (RVNC)
Revance Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-17 View latest technical analysis
10 day averaged volume of Revance Therapeutics is 6657483
| Date | Daily Closing Price | Open | High | Low | Volume |
| 17 Tue Sep 2024 | 5.97 | 6.02 | 6.27 | 5.85 | 0.832 times |
| 16 Mon Sep 2024 | 5.97 | 6.54 | 6.57 | 5.44 | 3.126 times |
| 13 Fri Sep 2024 | 6.55 | 6.58 | 6.59 | 6.54 | 1.581 times |
| 12 Thu Sep 2024 | 6.56 | 6.58 | 6.59 | 6.54 | 1.193 times |
| 11 Wed Sep 2024 | 6.58 | 6.57 | 6.59 | 6.56 | 0.446 times |
| 10 Tue Sep 2024 | 6.57 | 6.57 | 6.58 | 6.55 | 0.474 times |
| 09 Mon Sep 2024 | 6.58 | 6.58 | 6.59 | 6.57 | 0.38 times |
| 06 Fri Sep 2024 | 6.58 | 6.56 | 6.58 | 6.54 | 0.336 times |
| 05 Thu Sep 2024 | 6.57 | 6.58 | 6.58 | 6.55 | 1.427 times |
| 04 Wed Sep 2024 | 6.58 | 6.58 | 6.59 | 6.57 | 0.534 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 6.1, for a target of 6.3 or 6.52
Share price targets for Revance Therapeutics (RVNC)
| Target Type | Value |
| Downside Target | 2.30 |
| Downside Target | 2.40 |
| Downside Target | 2.59 |
| Downside Target | 2.76 |
| Downside Target | 3.21 |
| Downside Target | 4.39 |
| Downside Target | 4.48 |
| Downside Target | 5.44 |
| Upside Target | 6.54 |
| Upside Target | 6.59 |
| Upside Target | 6.60 |
| Upside Target | 6.65 |
Intraday share price targets for Revance Therapeutics (RVNC)
| Target Type | Value |
| Downside Intraday Target | 5.42 |
| Downside Intraday Target | 4.86 |
| Upside Intraday Target | 6.55 |
| Upside Intraday Target | 7.12 |
| Upside Intraday Target | 5.99 |
Weekly technical analysis of Revance Therapeutics (RVNC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 17 Tue Sep 2024 | 5.97 | 6.54 | 6.57 | 5.44 | 0.971 times |
| 13 Fri Sep 2024 | 6.55 | 6.58 | 6.59 | 6.54 | 1.455 times |
| 06 Fri Sep 2024 | 6.58 | 6.57 | 6.59 | 6.54 | 12.772 times |
| 30 Fri Aug 2024 | 6.57 | 6.57 | 6.59 | 6.57 | 0.139 times |
| 30 Fri Aug 2024 | 6.57 | 6.59 | 6.60 | 6.55 | 0.326 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Revance Therapeutics (RVNC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 17 Tue Sep 2024 | 5.97 | 6.57 | 6.59 | 5.44 | 0.447 times |
| 30 Fri Aug 2024 | 6.57 | 3.72 | 6.65 | 2.76 | 3.888 times |
| 31 Wed Jul 2024 | 3.78 | 2.57 | 4.39 | 2.40 | 1.188 times |
| 28 Fri Jun 2024 | 2.57 | 2.92 | 3.21 | 2.30 | 0.716 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Revance Therapeutics (RVNC)
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Revance Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Revance Therapeutics in short term but the sell signal is initial and weak.
Revance Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Revance Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Revance Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.34 and Revance Therapeutics (RVNC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Revance Therapeutics (RVNC) stock. Volume based technical analysis of Revance Therapeutics (RVNC) stock is negative.
Revance Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Revance Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Revance Therapeutics in short term but the sell signal is initial and weak.
Revance Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Revance Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Revance Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.34 and Revance Therapeutics (RVNC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Revance Therapeutics (RVNC) stock. Volume based technical analysis of Revance Therapeutics (RVNC) stock is negative.
Revance Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.